FDA approved acalabrutinib (Calquence) for the treatment of adults with mantle cell lymphoma who have received at least one prior therapy. More >

Download the latest edition of Research Report by the Lymphoma Research Foundation. More >

The Lymphoma Research Foundation invites you to take part in a mantle cell lymphoma patient survey, as part of the Foundation’s ongoing effort to learn more about the experience of people who have been diagnosed with mantle cell lymphoma (MCL). More >


Learn From Experts

The FocusOnMCL.org website is designed to provide helpful information and resources to patients, caregivers, physicians, and others affected by mantle cell lymphoma (MCL).

We invite you to browse the site to learn more about MCL.

Getting the Facts

Mantle cell lymphoma is a rare form of non-Hodgkin lymphoma (NHL), constituting only six percent of all NHL cases in the United States. It is considered an aggressive B-cell lymphoma and gets its name because mantle cell tumors are composed of cells that come from the “mantle zone” of the lymph node.

Recent Research

Recent research into mantle cell lymphoma has led to significant advancements in the understanding of the disease. Research continues on multiple fronts to develop better treatments for MCL patients. We hope you will find the information presented here useful in understanding your disease and discussing it with your healthcare team.

Ask the Doctor

LRF's Ask the Doctor About Lymphoma program is a national series of community based-programs which provide updates on lymphoma and new treatment options for patients.